Two advisory panels of the Food and Drug Administration will consider on Friday whether to recommend requiring women who use popular bone drugs like Fosamax to take “drug holidays†because of rising concerns about rare side effects with long-term use, according to people involved in the review.
F.D.A. to Review Safety of Popular Bone Drugs